The Feasibility of Omission of Postoperative Radiotherapy in Japanese Patients With Early Breast Cancer Treated With Breast-Conserving Surgery

被引:0
|
作者
Nakashima, Akihiro [1 ]
Yamazaki, Hideya [1 ]
Suzuki, Gen [2 ]
Yamada, Kei [1 ]
Aibe, Norihiro [1 ]
Kimoto, Takuya [1 ]
Masui, Koji [1 ]
Nakatsukasa, Katsuhiko [3 ]
Taguchi, Tetsuya [3 ]
Naoi, Yasuto [3 ]
机构
[1] Kyoto Prefectural Univ Med, Radiol, Kyoto, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Radiol, Kyoto, Japan
[3] Kyoto Prefectural Univ Med, Endocrine & Breast Surg, Kyoto, Japan
关键词
breast-conserving surgery; invasive carcinoma; omission of postoperative radiotherapy; postoperative radiotherapy; breast cancer; LUMPECTOMY PLUS TAMOXIFEN; IRRADIATION; WOMEN; OLDER; SURVIVAL; THERAPY; AGE;
D O I
10.7759/cureus.60228
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background This study was aimed at analyzing the impact of postoperative radiotherapy (PORT) after breast-conserving surgery (BCS) on Japanese patients with early-stage breast cancer and exploring the potential of PORT omission. Materials and methods Data from 794 patients with early-stage breast cancer (T1-2, N0-1), who underwent BCS with (n = 310) or without PORT (n = 484) were retrospectively analyzed. Local control (LC) rate and breast cancer-specific survival (BCSS) were compared between the groups that received and did not receive PORT in the whole cohort and low-risk cohort (i.e., the cohort with negative surgical margin, lymph node negativity, and estrogen receptor positivity, excluding young age of 49 or less), and in low-risk subgroup using propensityscore matching. Results PORT was associated with better LC but not BCSS in the total population. In the low-risk cohort, the incidence of local recurrence in patients without and with PORT was 5.3% and 4.8%, respectively, at 10 years (p = 0.591), and 7.8% and 4.8%, respectively, according to propensity-score matching (p = 0.485). Conclusion PORT improved LC in the total population, but not BCSS or overall survival (OS). In the low-risk group analysis (negative surgical margin, lymph node negativity, estrogen receptor positivity, and age 50 years or more), equivalent LC, BCSS, and OS were found including propensity-matched comparison. Therefore, this study showed that the omission of PORT could be a treatment option for low-risk Japanese patients. Further multi -center prospective studies are warranted to validate these findings and reduce the unnecessary burden of PORT for patients and institutions.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer
    Yu, Jeong
    Choi, Doo Ho
    Huh, Seung Jae
    Park, Won
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Jeong Eon
    Kill, Won Ho
    Im, Young-Hyuck
    Ahn, Jin Seok
    Park, Yeon Hee
    JOURNAL OF BREAST CANCER, 2015, 18 (01) : 50 - 56
  • [2] Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer
    不详
    BREAST, 2005, 14 : S32 - S32
  • [3] Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer A Review
    Speers, Corey
    Pierce, Lori J.
    JAMA ONCOLOGY, 2016, 2 (08) : 1075 - 1082
  • [4] Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer
    Han, Sehwan
    Kim, Juree
    Sohn, Seungchang
    Kwak, Geum-Hee
    Kim, Ji-Young
    Park, Kyeongmee
    JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (01) : 45 - 50
  • [5] The Feasibility of Omitting Postoperative Radiotherapy in Japanese Patients With Ductal Carcinoma In Situ of Breast Treated With Breast- Conserving Surgery
    Nakashima, Akihiro
    Yamazaki, Hideya
    Suzuki, Gen
    Yamada, Kei
    Norihiro, Aibe
    Kimoto, Takuya
    Masui, Koji
    Nakatsuka, Katsuhiko
    Taguchi, Tetsuya
    Naoi, Yasuto
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [6] EFFECTIVENESS OF RADIOTHERAPY TECHNIQUES AFTER BREAST-CONSERVING SURGERY IN PATIENTS WITH EARLY BREAST CANCER
    Trofimova, O. P.
    Mikhina, Z. P.
    Ivanov, S. M.
    Gutnik, R. A.
    Yazhgunovich, I. P.
    Vekova, N. V.
    Timoshkina, E. V.
    Poddubskaya, E. V.
    Tkachev, S. I.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2014, 6 (02) : 45 - 49
  • [7] Intraoperative radiotherapy in patients with breast cancer treated by breast-conserving therapy
    Zhang, Yan-jun
    Liu, Lei
    Ma, Lin
    Yu, Wei
    Liu, Mei
    Cheng, Liu-quan
    Li, Jie
    Zheng, Yi-qiong
    Wang, Jian-dong
    Kong, Qing-long
    Li, Xi-ru
    TUMORI JOURNAL, 2012, 98 (06): : 736 - 742
  • [8] Radiotherapy refusal in breast cancer with breast-conserving surgery
    Jiameng Liu
    Zhanlin Zhu
    Zhipeng Hua
    Weijie Lin
    Yiyin Weng
    Juli Lin
    Hehui Mao
    Lifen Lin
    Xuming Chen
    Jujiang Guo
    Radiation Oncology, 18
  • [9] Radiotherapy refusal in breast cancer with breast-conserving surgery
    Liu, Jiameng
    Zhu, Zhanlin
    Hua, Zhipeng
    Lin, Weijie
    Weng, Yiyin
    Lin, Juli
    Mao, Hehui
    Lin, Lifen
    Chen, Xuming
    Guo, Jujiang
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [10] Intraoperative radiotherapy in women with early breast cancer treated by breast-conserving therapy
    Chua, Boon H.
    Henderson, Michael A.
    Milner, Alvin D.
    ANZ JOURNAL OF SURGERY, 2011, 81 (1-2) : 65 - 69